This is just a glimpse. Want to receive every issue of Cannabis Wire Daily, our newsletter that is sent to subscribers each weekday morning, and unlimited access to cannabiswire.com? Subscribe today. A messy start in Minnesota. Well, that was fast. Late last week, we reported in this newsletter that Gov. Tim Walz named Erin DuPree as the first director
The post Minnesota’s messy start on regulating cannabis • WSWA’s new board chair • NCAA moves toward cutting cannabinoids from list of banned drugs • & more … appeared first on Cannabis Wire.
This is just a glimpse. Want to receive every issue of Cannabis Wire Daily, our newsletter that is sent to subscribers each weekday morning, and unlimited access to cannabiswire.com?
A messy start in Minnesota.
Well, that was fast. Late last week, we reported in this newsletter that Gov. Tim Walz named Erin DuPree as the first director of the state’s new Office of Cannabis Management, formed to oversee adult use cannabis. Walz called DuPree a “proven and effective leader.”
One day later, DuPree stepped down following a report from Minnesota Public Radio that her company, Loonacy Cannabis Co., sold products that exceeded the state’s allowable THC limits, and that DuPree had racked up tens of thousands of dollars in unpaid debts.
Until a new director is named, the interim position is held by Charlene Briner.
WSWA names new board chair.
Late last week, the Wine & Spirits Wholesalers of America (WSWA) announced Doug Shaw, the president of M.S. Walker, Inc., as Chairman of the Board.
Cannabis Wire is keeping a close eye on WSWA’s moves as they step deeper into the federal cannabis conversation, specifically with an eye on federal regulatory structure and distribution.
Shaw recently spoke to the association members during its annual membership meeting in Washington, D.C.
On the topic of the future of WSWA and strategic opportunities, Shaw highlighted “advocating for the comprehensive federal regulation of cannabis.”
NCAA moves toward removing cannabinoids from list of banned drugs.
After nearly a year of deliberations, the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports has formally called for the introduction and adoption of “legislation that would remove cannabinoids from the list of NCAA banned drug classes.”
Now, it is up to each of the NCAA’s three divisions to determine whether and how best to move forward. (More on the NCAA’s governance structure here.)
As Cannabis Wire previously reported in this newsletter, this conversation started in December at the Summit on Cannabinoids in College Athletics, during which, according to the NCAA, there was “consensus” that “cannabis is not a performance-enhancing drug and that a harm-reduction approach to cannabis is best implemented at the school level.”
“We are recommending a big shift in the paradigm when it comes to cannabinoids. We want to modernize the strategy with the most up-to-date research to give schools the best opportunity to support the health of student-athletes,” said committee chair James Houle in the announcement about the recommendation.